President Donald Trump appeared to walk back the success of Operation Warp Speed in a September Truth Social post, asking drug manufacturers whether the public received the full picture of the efficacy of the COVID-19 vaccines.
Trump initially called Operation Warp Speed a monumental national achievement, highlighting its rapid approval. He said, “Before Operation Warp Speed, the typical timeframe for development and approval could be infinity. We were happy to get things done at a level nobody had ever seen before.”
In his recent post, Trump distanced himself from what he once called the “gold standard vaccine,” which earned him bipartisan praise and scrutiny over the shortened research timeline and potential long-term effects.
His call for the release of the data by Pfizer and others comes after a series of resignations at the Center for Disease Control (CDC) and ahead of the Advisory Committee on Immunization Practices (ACIP) meeting set for Sept. 18-19.
The agenda includes consideration of several childhood immunizations as well as the COVID-19 vaccines. CDC changes under Trump’s appointee, Robert F. Kennedy Jr., have been a frequent target of criticism from the medical establishment, with the American Academy of Pediatrics and other groups going so far as to sue him over the removal of the COVID-19 vaccine from the childhood schedule.
Kennedy has also faced internal pressure from colleagues inside Health and Human Services, with a petition to remove him from the department gaining more than 1,000 signatures. (RELATED: Wausau Alderman Under Fire: Citizens Demand Resignation After Blaming Charlie Kirk For His Own Assassination)
Trump appears to have grown impatient with the inconsistency of the data shown to him versus what has been released to the public by the vaccine manufacturers. His call for transparency in COVID-19 vaccine data follows years of conflict and court battles. Among them was a Freedom of Information Act request where Pfizer asked for 75 years to publicly disclose the data they used for their COVID-19 vaccine.
Credibility issues and the slow-paced release of COVID-19 vaccine data fueled the already low public trust in the CDC. The issues began well before Kennedy’s appointment. One research study published in RAND Health examined the decline noting the uphill battle for the CDC to rebuild trust. Kennedy, who campaigned on addressing the chronic disease crisis, recently released an op-ed outlining how he will work to regain public trust in our health care institutions highlighting the CDC’s recent mobilization during the measles outbreak.
Restoring trust is essential to a functioning civil society and it appears to be a goal of the Trump administration as they investigate pandemic response efforts by drug manufacturers. As Trump works to unleash the Make America Healthy Again (MAHA) movement, his defense of Kennedy’s work at HHS displays a united administration. (RELATED: Charlotte Judge Faces Heat After Freeing Killer Who Murdered Refugee)
